Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease-Reference-Cited by-同舟云学术

Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease

Published:2022-04-08 Issue:8 Volume:216 Page:385-387
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Nidorf Stefan M¹²,Layland Jamie³,Robinson Philip C⁴⁵,Patel Sanjay⁶⁷,Psaltis Peter J⁸⁹,Thompson Peter L²¹⁰¹¹

Affiliation:

1. Genesis Care Perth WA

2. Heart and Vascular Research Institute Harry Perkins Institute of Medical Research Perth WA

3. Monash University Melbourne VIC

4. University of Queensland Brisbane QLD

5. Royal Brisbane Hospital Brisbane QLD

6. Royal Prince Alfred Hospital Sydney NSW

7. University of Sydney Sydney NSW

8. Royal Adelaide Hospital Adelaide SA

9. Vascular Research Centre Heart Health Theme South Australian Health and Medical Research Institute Adelaide SA

10. Sir Charles Gairdner Hospital Perth WA

11. University of Western Australia Perth WA

Funder

National Health and Medical Research Council

University of Western Australia

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja2.51488

Reference21 articles.

1. Australian Institute of Health and Welfare.Heart stroke and vascular disease — Australian facts 2021.https://www.aihw.gov.au/reports/heart‐stroke‐vascular‐diseases/hsvd‐facts/contents/about(viewed Jan 2021).

2. Colchicine and the heart

3. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview

4. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability

5. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management;Drug Safety;2022-12-15